Obesity Clinical Trial
— ACTIONOfficial title:
Awareness, Care & Treatment in Obesity Management (ACTION) Study
Verified date | July 2019 |
Source | Novo Nordisk A/S |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.
Status | Completed |
Enrollment | 3767 |
Est. completion date | November 12, 2015 |
Est. primary completion date | November 12, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - GENERAL POPULATION - Agrees to AE reporting - Age at least 18 years - Lives in the US - Current BMI at least 30 kg/sqm - HEALTH CARE PROFESSIONALS - Agrees to AE reporting - Physician and board certified or NP/PA - Facility located in the U.S. and not Vermont - Spends at least 70% of time in direct patient care - Seen at least 100 patients in past month - Seen at least 10 patients in past month needing weight management - In practice 2-35 years - Not competitively employed - Primary Care Providers - Specialty is FP, IM, GP - Less than 50% patients seen for obesity - Obesity Specialists - Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity - In practice 2-35 years - EMPLOYERS - Age at least 18 years - Works in the US - Director, Administrator, CHRO, VP or other title - Responsible for making or influencing decisions about health insurance or health and wellness programs - Company employs 500 or more full-time employees - Believes there is a weight issue at their company - Not competitively employed Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United States | Novo Nordisk Investigational Site | Honeoye Falls | New York |
Lead Sponsor | Collaborator |
---|---|
Novo Nordisk A/S |
United States,
Jinnett K, Kyle T, Parry T, Stevenin B, Ramasamy A. Insights into the Role of Employers Supporting Obesity Management in People with Obesity: Results of the National ACTION Study. Popul Health Manag. 2018 Oct 31. doi: 10.1089/pop.2018.0133. [Epub ahead of — View Citation
Kaplan LM, Golden A, Jinnett K, Kolotkin RL, Kyle TK, Look M, Nadglowski J, O'Neil PM, Parry T, Tomaszewski KJ, Stevenin B, Lilleøre SK, Dhurandhar NV. Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study. Obesity (Sil — View Citation
Look M, Kolotkin RL, Dhurandhar NV, Nadglowski J, Stevenin B, Golden A. Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study. Postgrad Med. 2019 Jun;131(5):357-365. doi: 10.10 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Awareness with the care and management of obesity among people with obesity | Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design | Start of interviews day 1 until day 15 | |
Primary | Awareness with the care and management of obesity among health care providers | Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design | Start of interviews day 1 until day 15 | |
Primary | Awareness with the care and management of obesity among employer representatives | Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design | Start of interviews day 1 until day 15 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |